Países Bajos

¡Bienvenido/a! En esta página encontrarás las últimas noticias legales, publicaciones y eventos en Países Bajos. Para mantenerte al corriente de las últimas novedades, guarda esta página en tu teléfono móvil o regístrate para recibir alertas electrónicas.

CMS es clave en Países Bajos: para obtener más información, haga clic aquí.

Artículos Recientes

  •  
    24/05/2024
    Europe

    EU anti-dumping investigations for Chinese lysine and vanillin imports

    On 23 May 2024, the EU opened an anti-dumping investigation concerning EU imports of lysine originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.On 24 May 2024, the EU opened another anti-dumping investigation concerning EU imports of vanillin originating in the People’s Republic of China, which could lead to substantial anti-dumping duties on future imports.Lysine investigationThe products under investigation for alleged dumping are “lysine and its esters, salts thereof, and feed additives, consisting...
    Leer más
  •  
    22/05/2024
    Europe

    The EU Gigabit Infrastructure Act: Faster, Cheaper and Simpler Rollout of High-Speed Networks

    The EU Gigabit Infrastructure Act (GIA), which is set to become law after a political agreement reached in February 2024, responds to the ever-growing need for faster, more reliable, data-intensive connectivity in Europe. The key purpose of the GIA is to replace the 2014 Broadband Cost Reduction Directive and to facilitate the rollout of very high-capacity networks (VHCN) by addressing identified roadblocks such as expensive and complex procedures for network deployment. It is part of the EU’s wider goal of deploying gigabit-capable infrastructure across the EU by 2030.Main Objectives...
    Leer más
  •  
    21/05/2024
    EU

    Consultation of the European Commission on Vifor's commitments concerning the potential abuse of dominant position due to possible anticompetitive disparagement of iron medicine

    GB FR
    In response to the Preliminary Assessment stating the potential abuse of its dominant position, Vifor proposed several commitments to rectify the potential competition law infringement. The European Commission had initiated an antitrust investigation in June 2022 against Vifor to determine if it unfairly disparaged its competitor, Pharmacosmos, by spreading misleading information about the safety of its product, Monofer. Vifor Pharma, dominant in several EEA markets, faces accusations of abusing its position, potentially violating competition law. In its proposal, Vifor proposed several commitments...
    Leer más
  •  
    17/05/2024
    Europe

    European Sanctions: Mandatory Contract Clauses, New Criminal Penalties

    BackgroundFollowing Russia’s occupation of Crimea in 2014 and invasion of Ukraine in 2022, global allies including the UK, US and EU, Canada and Australia, acted in concert to impose stringent sanctions and export control restrictions designed to stem the flow of investment into the Russian war machine. These included wide restrictions on the goods and their components found on the battlefield in Ukraine, and is reflected in the G7 agreed list of Common High Priority Items.The two years since have seen the growth of a shadow “evasion” economy, used by supporters of the Russian...
    Leer más
  •  
    16/05/2024
    Europe

    A broader interpretation of "substance or composition" - good news for patentees at the EPO?

    A recent decision from the EPO Boards of Appeal (T 1252/20) potentially paves the way for more diverse products to be patentable in Europe using the medical use claim format.The background:Article 53(c) of the European Patent Convention (EPC) excludes methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body from patentability. However, this does not apply to products, in particular substances or compositions, for use in any of these methods.Furthermore, Articles 54(4) and (5) EPC provide that a claim to a known substance...
    Leer más
  •  
    15/05/2024
    EU

    The European Commission reports on the open and targeted consultations on the SFDR assessment

    BackgroundThe Sustainable Finance Disclosures Regulation (SFDR1) applies since March 2021 with a view to providing transparency to investors about the sustainability risks associated with their investments and potential adverse impacts such investments have on the environment and society.On 14 September 2023, the European Commission (the EC) published two consultation papers on SFDR. On the one hand, an open consultation on the practical implementation of SFDR aimed at a broader range of stakeholders with a more general knowledge of SFDR (the Open Consultation). On the other hand, a target consultation...
    Leer más